Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus.
about
Cardiac Natriuretic Peptides, Hypertension and Cardiovascular RiskTranscriptome profiling reveals novel BMI- and sex-specific gene expression signatures for human cardiac hypertrophy.Integrating Biomarkers and Imaging for Cardiovascular Disease Risk Assessment in Diabetes.Multifaceted interaction of bone, muscle, lifestyle interventions and metabolic and cardiovascular disease: role of osteocalcin.Diabetic Cardiomyopathy: Current Approach and Potential Diagnostic and Therapeutic Targets.Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study.Increased Soluble VCAM-1 and Normal P-Selectin in Cystic Fibrosis: a Cross-Sectional StudyKDM3A inhibition attenuates high concentration insulin‑induced vascular smooth muscle cell injury by suppressing MAPK/NF‑κB pathways.Biomarkers for cardiovascular risk in patients with diabetes.Biomarkers of cardiovascular disease: contributions to risk prediction in individuals with diabetes.Bone markers and cardiovascular risk in type 2 diabetes patients.The early economic evaluation of novel biomarkers to accelerate their translation into clinical applications.Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice
P2860
Q33715302-2EA293FD-ADE4-4508-89CC-9B4F87ECE8D9Q38788545-FE116725-AA24-4AF9-9B55-3773D9392E93Q38950340-742986A4-F4C5-42EE-983D-78CE3C9CB42BQ39176937-3A00DB8C-0A4C-48F9-9A98-27B875C57EE6Q39249730-AE4C78F3-2A82-4CAC-818F-A75D78DC1473Q40094602-927691C7-1CBD-4F29-AFEF-F6683BCF1203Q41096059-E3A4C051-B6B6-4DDB-A57F-AE71F0D61891Q47246628-89615690-1E88-4413-B7F4-DC46CE065CE6Q48359696-5D7B0969-6CA2-4ACE-9B67-17BFC3FEF662Q49691813-5066FC46-B179-470C-A746-1B67BD27F772Q53738261-C11C73ED-DB6D-4C63-B438-929A60C8F9D7Q55315552-D40CF3F1-D739-4B6D-A652-62FD210B4027Q58762112-79F73D51-8BA2-42B3-AFEA-3057CF20033F
P2860
Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel Biomarkers to Improve th ...... k in Type 2 Diabetes Mellitus.
@en
Novel Biomarkers to Improve th ...... k in Type 2 Diabetes Mellitus.
@nl
type
label
Novel Biomarkers to Improve th ...... k in Type 2 Diabetes Mellitus.
@en
Novel Biomarkers to Improve th ...... k in Type 2 Diabetes Mellitus.
@nl
prefLabel
Novel Biomarkers to Improve th ...... k in Type 2 Diabetes Mellitus.
@en
Novel Biomarkers to Improve th ...... k in Type 2 Diabetes Mellitus.
@nl
P2093
P2860
P921
P356
P1476
Novel Biomarkers to Improve th ...... sk in Type 2 Diabetes Mellitus
@en
P2093
Casper G Schalkwijk
Jan F C Glatz
Joep van der Leeuw
Jolanda M A Boer
Joline W J Beulens
Linda M Peelen
Marten H Hofker
Susan van Dieren
W M Monique Verschuren
Yolanda van der Graaf
P2860
P356
10.1161/JAHA.115.003048
P577
2016-05-31T00:00:00Z